Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Pre-motor features of Parkinson's disease: the Honolulu-Asia Aging Study experience.

Ross GW, Abbott RD, Petrovitch H, Tanner CM, White LR.

Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S199-202. doi: 10.1016/S1353-8020(11)70062-1. Review.

PMID:
22166434
2.

Association of olfactory dysfunction with risk for future Parkinson's disease.

Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K, Launer L, White LR.

Ann Neurol. 2008 Feb;63(2):167-73.

PMID:
18067173
3.

Environmental, life-style, and physical precursors of clinical Parkinson's disease: recent findings from the Honolulu-Asia Aging Study.

Abbott RD, Ross GW, White LR, Sanderson WT, Burchfiel CM, Kashon M, Sharp DS, Masaki KH, Curb JD, Petrovitch H.

J Neurol. 2003 Oct;250 Suppl 3:III30-9.

PMID:
14579122
4.

Bowel movement frequency in late-life and incidental Lewy bodies.

Abbott RD, Ross GW, Petrovitch H, Tanner CM, Davis DG, Masaki KH, Launer LJ, Curb JD, White LR.

Mov Disord. 2007 Aug 15;22(11):1581-6.

PMID:
17523195
5.

[Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease].

Wakabayashi K, Takahashi H, Oyanagi K, Ikuta F.

No To Shinkei. 1993 Nov;45(11):1033-8. Japanese. Erratum in: No To Shinkei 1993 Dec;45(12):1133.

PMID:
8135950
6.
7.

Parkinsonian signs and substantia nigra neuron density in decendents elders without PD.

Ross GW, Petrovitch H, Abbott RD, Nelson J, Markesbery W, Davis D, Hardman J, Launer L, Masaki K, Tanner CM, White LR.

Ann Neurol. 2004 Oct;56(4):532-9.

PMID:
15389895
8.

Excessive daytime sleepiness and subsequent development of Parkinson disease.

Abbott RD, Ross GW, White LR, Tanner CM, Masaki KH, Nelson JS, Curb JD, Petrovitch H.

Neurology. 2005 Nov 8;65(9):1442-6.

PMID:
16275833
9.
10.

Low LDL cholesterol and increased risk of Parkinson's disease: prospective results from Honolulu-Asia Aging Study.

Huang X, Abbott RD, Petrovitch H, Mailman RB, Ross GW.

Mov Disord. 2008 May 15;23(7):1013-8. doi: 10.1002/mds.22013.

PMID:
18381649
11.

Parkinson's disease risk score: moving to a premotor diagnosis.

Winkler J, Ehret R, Büttner T, Dillmann U, Fogel W, Sabolek M, Winkelmann J, Kassubek J.

J Neurol. 2011 May;258(Suppl 2):S311-5. doi: 10.1007/s00415-011-5952-x. Review.

PMID:
21560061
12.

Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.

Jellinger KA.

Acta Neuropathol. 2003 Sep;106(3):191-201. Epub 2003 Jul 5. Erratum in: Acta Neuropathol (Berl). 2003 Dec;106(6):588.

PMID:
12845452
13.

When does Parkinson's disease begin?

Gaig C, Tolosa E.

Mov Disord. 2009;24 Suppl 2:S656-64. doi: 10.1002/mds.22672. Review.

PMID:
19877243
14.

The locus ceruleus and dementia in Parkinson's disease.

Zweig RM, Cardillo JE, Cohen M, Giere S, Hedreen JC.

Neurology. 1993 May;43(5):986-91.

PMID:
8492957
15.

Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease.

Postuma RB, Aarsland D, Barone P, Burn DJ, Hawkes CH, Oertel W, Ziemssen T.

Mov Disord. 2012 Apr 15;27(5):617-26. doi: 10.1002/mds.24996. Review.

PMID:
22508280
16.
17.

Bowel movement frequency in late-life and substantia nigra neuron density at death.

Petrovitch H, Abbott RD, Ross GW, Nelson J, Masaki KH, Tanner CM, Launer LJ, White LR.

Mov Disord. 2009 Feb 15;24(3):371-6. doi: 10.1002/mds.22360.

18.

Sleep-wake changes in the premotor stage of Parkinson disease.

Iranzo A.

J Neurol Sci. 2011 Nov 15;310(1-2):283-5. doi: 10.1016/j.jns.2011.07.049. Epub 2011 Aug 30. Review.

PMID:
21880334
19.

Clinical measures of progression in Parkinson's disease.

Poewe W.

Mov Disord. 2009;24 Suppl 2:S671-6. doi: 10.1002/mds.22600. Review.

PMID:
19877235
20.

Executive functions and disease characteristics in Parkinson's disease.

Van Spaendonck KP, Berger HJ, Horstink MW, Buytenhuijs EL, Cools AR.

Neuropsychologia. 1996 Jul;34(7):617-26.

PMID:
8783214

Supplemental Content

Support Center